If You Have Type 1 Diabetes Up to now, the FDA has not approved any GLP-1 or dual GIP/GLP-1 drugs for treating type 1 diabetes
Both scenarios happen more often than anyone in the telehealth industry wants to admit, and the FDA has documented hospitalizations from exactly this type of error
The clearest way to find out is a consultation
For more information, call 1-800-LillyRx (1-800-545-5979)
Persistent or worsening nausea beyond this timeframe should prompt reassessment for drug interactions, alternative diagnoses (e.g., gastroparesis), or consideration of anti-nausea medications
Safety in Context: Study Limitations While the clinical trial safety data for AOD-9604 is extensive and reassuring, understanding the limitations of this evidence base is essential for balanced interpretation